Comment on: Muscle fluorodeoxyglucose uptake assessed by positron emission tomography-computed tomography as a biomarker of inflammatory myopathies disease activity

Rheumatology (Oxford). 2019 Dec 1;58(12):2344-2345. doi: 10.1093/rheumatology/kez425.

Authors

Nihal Martis^{1

2}, Michael Levraut^{1

2}, Olivier Humbert^{2

3}, Olivier Lidove⁴

Affiliations

¹ Department of Internal Medicine, Centre Hospitalier Universitaire de Nice, Nice, Paris, France.
² Faculty of Medicine, Université Côte d'Azur, Nice, Paris, France.
³ Department of Nuclear Medicine, Centre Antoine Lacassagne, Nice, Paris, France.
⁴ Department of Internal Medicine, Groupe Hospitalier Diaconesses-Croix St-Simon, Paris, France.

PMID: 31608941
DOI: 10.1093/rheumatology/kez425

No abstract available

Publication types

Letter
Comment

MeSH terms

Biomarkers
Fluorodeoxyglucose F18
Humans
Myositis*
Positron Emission Tomography Computed Tomography*
Positron-Emission Tomography

Substances

Biomarkers
Fluorodeoxyglucose F18